Archives
-
Sulfo-NHS-SS-Biotin for Spatial Surface Proteomics
2026-09-20
Sulfo-NHS-SS-Biotin enables reversible surface-protein capture while preserving a clear distinction between extracellular labeling and proximity proteomics. This guide uses Notch receptor interactome research to explain assay design, controls, enrichment, and interpretation.
-
Eicosapentaenoic Acid: Assay Design That Holds Up
2026-09-19
Eicosapentaenoic Acid (EPA) is more than an EPA omega-3 fatty acid with cardiovascular relevance: its concentration-dependent biology demands disciplined assay design. This article connects EPA membrane pharmacology with lessons from recent arachidonic acid vaccine research while defining practical boundaries for cardiovascular disease research.
-
Cabazitaxel (XRP6258): Practical Protocol Guide
2026-09-18
Cabazitaxel (XRP6258, SKU B2157) is a semi-synthetic taxoid derivative used to study microtubule dynamics disruption and antiproliferative responses, including models with P-glycoprotein-associated taxane resistance. This guide covers DMSO- and ethanol-based preparation, matched vehicle controls, prompt solution use, and the limitations of applying an insoluble compound to aqueous workflows.
-
CHI3L1-IN-5: From Mechanism to Translation
2026-09-18
A translational perspective on CHI3L1-IN-5 (Compound Z17) as a CNS-penetrant tool for connecting CHI3L1-mediated NF-κB signaling with astrocyte amyloid handling, while clarifying assay strategy, compound identity, and the limits of cross-domain interpretation.
-
Reliable (S)-Mephenytoin CYP2C19 Assays
2026-09-17
A scenario-based guide to using (S)-Mephenytoin, SKU C3414, as a defined CYP2C19 substrate alongside cell viability, proliferation, and cytotoxicity workflows. It covers model selection, solvent control, kinetic interpretation, organoid compatibility, and practical vendor evaluation without treating a metabolism probe as a direct viability reagent.
-
GTP Solution: From IVT Quality to mRNA Insight
2026-09-17
GTP Solution (100 mM) is more than a nucleotide stock: it is a controllable variable in IVT mRNA workflows. This article connects GTP chemistry, reagent handling, and assay interpretation to the localized p21 mRNA–LNP bladder cancer study without confusing upstream RNA quality with therapeutic efficacy.
-
BMS 309403: FABP4 Inhibitor Workflow
2026-09-16
BMS 309403 enables selective interrogation of FABP4-dependent lipid handling, macrophage inflammation, and foam-cell formation. This practical guide connects dose–time experiments with the SERCA2–calcineurin–FoxO1–FABP4 mechanism and provides controls for atherosclerosis and metabolic-disease studies.
-
Self-Amplifying RNA Vaccines for Seasonal Influenza
2026-09-16
The reference study shows that self-amplifying RNA can overcome important strain-specific limitations of conventional mRNA influenza vaccines, particularly for influenza B. Its low-dose trivalent saRNA candidate produced durable antibody responses and complete protection in mouse challenge experiments, supporting further investigation of dose-sparing RNA vaccine designs.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-09-15
AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer cell proliferation, and metabolism. It is best suited to preclinical mechanistic workflows and should not be used to infer clinical efficacy or replace formulation development for aqueous systems.
-
IPR-803: Urokinase Receptor Inhibitor Workflow
2026-09-15
IPR-803 is a competitive uPAR inhibitor for separating tumor invasion biology from simple effects on migration, adhesion, or proliferation. This workflow connects dose-controlled breast cancer assays with pancreatic tumor-stroma research, including formulation strategies designed to improve gemcitabine delivery.
-
Pertussis Toxin in Causal Signaling Assays
2026-09-14
Pertussis toxin can do more than perturb immune signaling: it can help test whether Gi/o-linked pathways causally shape complex biological outcomes. This article connects dendritic-cell assays, cAMP biology, and the 2024 DOM mouse study while emphasizing controls, interpretation, and product handling.
-
Syringin, Sunitinib, and EGFR/PI3K/Akt in RCC
2026-09-14
A 2024 Journal of Functional Foods study identifies syringin as a potential adjunct to sunitinib in renal cell carcinoma by combining network pharmacology, molecular docking, and cell-based validation. The findings associate syringin treatment with reduced RCC cell growth and migration, increased apoptosis, and modulation of the EGFR/PI3K/Akt pathway, while also highlighting the need for in vivo and clinical confirmation.
-
Tetramethylrhodamine Ethyl Ester: TMRE C8197
2026-09-13
Tetramethylrhodamine ethyl ester perchlorate (TMRE) enables membrane-potential measurements that connect mitochondrial physiology with trichothecene-induced injury. This article explains how TMRE C8197 can distinguish mitochondrial depolarization from broader ROS and apoptosis signals while supporting rigorous live-cell assay design.
-
CHI3L1-IN-5: Astrocyte Assay Workflows
2026-09-12
CHI3L1-IN-5, also called Compound Z17, supports a paired workflow that connects CHI3L1-mediated NF-κB signaling with astrocyte Aβ handling and lysosomal recovery. This guide separates target-pathway evidence from functional rescue, helping researchers optimize exposure, controls, and interpretation without confusing this neuroinflammation tool with an unrelated ALDH2 compound that shares the Z17 label.
-
Cy7 NHS Ester: Practical Labeling and QC Guide
2026-09-11
Cy7 NHS ester (SKU A8109) is a water-soluble, sulfonated near-infrared reagent for labeling accessible amino groups on proteins, peptides, and related biomolecules. It is useful for aqueous conjugation and near-infrared imaging workflows, but it is not appropriate for targets without accessible amines or for long-term storage of prepared dye solutions.